Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Hatteras Venture Partners

WebsiteLinkedIncbCrunchbase
Status
ACTIVE
Global HQ
District of Columbia, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Data science
About
Hatteras Venture Partners is a preclinical stage startup that specializes in developing a versatile epigenetic editing platform aimed at creating innovative solutions for various medical applications, particularly in the field of human medicine.
Min check size
$100K
Max check size
$1M
Fund size
NPS

Investment Thesis

Hatteras Venture Partners’ investment thesis is centered on identifying and investing in earlystage companies with transformative technologies in healthcare and life sciences. The firm targets startups with strong scientific foundations, promising clinical and commercial potential, and capable management teams.
Lead investor
Co Invest
Number of exits
Preferred contact method

Hatteras Venture Partners Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp